"Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H1 2013" Now Available at Fast Market Research
Global Markets Direct's, 'Relapsing Multiple Sclerosis (RMS) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Relapsing Multiple Sclerosis (RMS), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Relapsing Multiple Sclerosis (RMS). Relapsing Multiple Sclerosis (RMS) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release